Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease
- DOI
- 10.1681/asn.0000001271
- Published
- 2026-10-24
- Container
- Journal of the American Society of Nephrology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1681/asn.0000001271,
title = {Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease},
author = {Stephen L. Seliger and Berenice Gitomer and Zhiying You and Wei Wang and Anna Ostrow and Emily Andrews and Charalett Diggs and Diana George and Miranda West and Kristen L. Nowak and Terry Watnick and Michel Chonchol},
year = {2026},
journal = {Journal of the American Society of Nephrology},
doi = {10.1681/asn.0000001271},
url = {https://doi.org/10.1681/asn.0000001271}
}RIS
TY - JOUR TI - Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease AU - Stephen L. Seliger AU - Berenice Gitomer AU - Zhiying You AU - Wei Wang AU - Anna Ostrow AU - Emily Andrews AU - Charalett Diggs AU - Diana George AU - Miranda West AU - Kristen L. Nowak AU - Terry Watnick AU - Michel Chonchol PY - 2026 JO - Journal of the American Society of Nephrology DO - 10.1681/asn.0000001271 UR - https://doi.org/10.1681/asn.0000001271 ER -
APA
Seliger, S. L., Gitomer, B., You, Z., Wang, W., Ostrow, A., Andrews, E., Diggs, C., George, D., West, M., Nowak, K. L., Watnick, T., & Chonchol, M. (2026). Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001271
Source records
- crossref · retrieved 2026-11-10T06:37:39.202Z